Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Hyperplasia

17 alpha-hydroxyprogesterone caproate has been researched along with Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huo, Z; Lang, JH; Shen, K; Wu, M; Yang, JX; Yu, M1
Adamian, RT1

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Hyperplasia

ArticleYear
[Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants].
    Voprosy onkologii, 2001, Volume: 47, Issue:3

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Anticoagulants; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Hyperplasia; Medroxyprogesterone Acetate; Neoplasm Staging; Progesterone Congeners; Treatment Outcome

2001

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Hyperplasia

ArticleYear
Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
    Fertility and sterility, 2009, Volume: 92, Issue:6

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Cell Differentiation; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Female; Fertility; Follow-Up Studies; Humans; Hydroxyprogesterones; Hyperplasia; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Progestins; Remission Induction; Reproductive Techniques, Assisted; Retrospective Studies; Severity of Illness Index

2009